PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind
SOURCE
Related Articles Read More >
Catching up with Dr. Tom Oxley as Synchron builds toward a pivotal trial for FDA approval of its Stentrode BCI
Sept. 25-26: Live interviews and audience Q&As with minimally invasive engineers from J&J, Abbott and more
As cardiovascular deaths soar for women, Medtronic’s Nina Goodheart and the medtech industry are responding
